Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato]

DRUG2 trials

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions

Critically Ill PatientsSurgical Injury

Early Phase 1

Esketamine Induction Intubation in ICU Patients.

CompletedNCT05464979

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCritically Ill Patients

Start: 2022-08-27End: 2023-06-28Updated: 2026-07-21

Phase 4

Prophylactic Effects of Esketamine in Surgical Patients

WithdrawnNCT05180318

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologySurgical Injury

Start: 2024-10-01End: 2024-12-31Updated: 2024-04-29

Related Papers

Efficacy and safety of esketamine for emergency endotracheal intubation in ICU patients: a double-blind, randomized controlled clinical trial.

2025-02-192 citations